Cargando…

ZHX2 mediates proteasome inhibitor resistance via regulating nuclear translocation of NF‐κB in multiple myeloma

BACKGROUND: Multiple myeloma (MM) is an incurable hematological malignancy. Although proteasome inhibitors and immunomodulators have significantly improved patient outcomes, some patients respond poorly to treatment and almost all patients will relapse. Mechanisms of proteasome inhibitor resistance...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Jifeng, Sun, Yifeng, Xu, Jiadai, Xu, Tianhong, Xu, Zhao, Liu, Peng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Cancer Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7541163/ https://www.ncbi.nlm.nih.gov/pubmed/32780537 http://dx.doi.org/10.1002/cam4.3347

Ejemplares similares

High Expression of Succinate Dehydrogenase Subunit A Which Is Regulated by Histone Acetylation, Acts as a Good Prognostic Factor of Multiple Myeloma Patients
por: Sun, Yifeng, et al.
Publicado: (2020)

ZHX2 promotes HIF1α oncogenic signaling in triple-negative breast cancer
por: Fang, Wentong, et al.
Publicado: (2021)

Distinct predictive impact of FISH abnormality in proteasome inhibitors and immunomodulatory agents response: redefining high‐risk multiple myeloma in Asian patients
por: Byun, Ja Min, et al.
Publicado: (2018)

Globular C1q Receptor (gC1qR/p32/HABP1) Suppresses the Tumor-Inhibiting Role of C1q and Promotes Tumor Proliferation in 1q21-Amplified Multiple Myeloma
por: Xu, Jiadai, et al.
Publicado: (2020)

Paradoxical resistance of multiple myeloma to proteasome inhibitors by decreased levels of 19S proteasomal subunits
por: Acosta-Alvear, Diego, et al.
Publicado: (2015)

The combination of a sphingosine kinase 2 inhibitor (ABC294640) and a Bcl‐2 inhibitor (ABT‐199) displays synergistic anti‐myeloma effects in myeloma cells without a t(11;14) translocation
por: Sundaramoorthy, Pasupathi, et al.
Publicado: (2018)

USP13 promotes deubiquitination of ZHX2 and tumorigenesis in kidney cancer
por: Xie, Haibiao, et al.
Publicado: (2022)

IRF3 inhibits nuclear translocation of NF-κB to prevent viral inflammation
por: Popli, Sonam, et al.
Publicado: (2022)

Isoalantolactone inhibits IKKβ kinase activity to interrupt the NF‐κB/COX‐2‐mediated signaling cascade and induces apoptosis regulated by the mitochondrial translocation of cofilin in glioblastoma
por: Xing, Jin‐Shan, et al.
Publicado: (2019)

Syrbactin-class dual constitutive- and immuno-proteasome inhibitor TIR-199 impedes myeloma-mediated bone degeneration in vivo
por: Tandon, Vasudha, et al.
Publicado: (2022)

GABA(B)R/GSK‐3β/NF‐κB signaling pathway regulates the proliferation of colorectal cancer cells
por: Shu, Qing, et al.
Publicado: (2016)

Proteasome Inhibitors for the Treatment of Multiple Myeloma
por: Ito, Shigeki
Publicado: (2020)

Single-Cell Transcriptomes Combining with Consecutive Genomics Reveal Clonal Evolution and Gene Regulatory Networks in Relapsed and Refractory Multiple Myeloma
por: Xu, Jiadai, et al.
Publicado: (2022)

Pard3 suppresses glioma invasion by regulating RhoA through atypical protein kinase C/NF‐κB signaling
por: Li, Junjun, et al.
Publicado: (2019)

Epigenetic silencing of ADAMTS18 promotes cell migration and invasion of breast cancer through AKT and NF‐κB signaling
por: Xu, Hongying, et al.
Publicado: (2017)

Low expression of ZHX1 and ZHX2 impacts on the prognosis of chronic lymphocytic leukemia
por: Maciel, Natália Ioseph Gladistone, et al.
Publicado: (2021)

Epigenomic reprogramming via HRP2-MINA dictates response to proteasome inhibitors in multiple myeloma with t(4;14) translocation
por: Wang, Jingjing, et al.
Publicado: (2022)

Human primed ILCPs support endothelial activation through NF-κB signaling
por: Vanoni, Giulia, et al.
Publicado: (2021)

Ubiquitin‐specific peptidase 53 inhibits the occurrence and development of clear cell renal cell carcinoma through NF‐κB pathway inactivation
por: Gui, Dingwen, et al.
Publicado: (2021)

A Machine Learning Model to Predict Survival and Therapeutic Responses in Multiple Myeloma
por: Ren, Liang, et al.
Publicado: (2023)

Immunoglobulin Free Light Chains and GAGs Mediate Multiple Myeloma Extracellular Vesicles Uptake and Secondary NfκB Nuclear Translocation
por: Di Noto, Giuseppe, et al.
Publicado: (2014)

ZHX2 in health and disease
por: Li, Na, et al.
Publicado: (2022)

The role of mmu‐miR‐155‐5p‐NF‐κB signaling in the education of bone marrow‐derived mesenchymal stem cells by gastric cancer cells
por: Wang, Mei, et al.
Publicado: (2018)

Helicobacter pylori‐induced YAP1 nuclear translocation promotes gastric carcinogenesis by enhancing IL‐1β expression
por: Wu, Yujiao, et al.
Publicado: (2019)

Activation of PTGS2/NF‐κB signaling pathway enhances radiation resistance of glioma
por: Tan, Cheng, et al.
Publicado: (2019)

New proteasome inhibitors in the treatment of multiple myeloma
por: Hungria, Vania Tietsche de Moraes, et al.
Publicado: (2019)

The mechanism study of miR‐125b in occurrence and progression of multiple myeloma
por: Gao, Da, et al.
Publicado: (2017)

Potent anti‐myeloma activity of the TOPK inhibitor OTS514 in pre‐clinical models
por: Stefka, Andrew T., et al.
Publicado: (2019)

Proteasome Inhibition Activates Autophagy-Lysosome Pathway Associated With TFEB Dephosphorylation and Nuclear Translocation
por: Li, Chunyan, et al.
Publicado: (2019)

lncRNA‐NKILA/NF‐κB feedback loop modulates laryngeal cancer cell proliferation, invasion, and radioresistance
por: Yang, Tao, et al.
Publicado: (2018)

Sam68/KHDRBS1 is critical for colon tumorigenesis by regulating genotoxic stress-induced NF-κB activation
por: Fu, Kai, et al.
Publicado: (2016)

Clinical Use of Proteasome Inhibitors in the Treatment of Multiple Myeloma
por: Merin, Noah M., et al.
Publicado: (2014)

Ixazomib: An Oral Proteasome Inhibitor for the Treatment of Multiple Myeloma
por: Ramirez, Krista G.
Publicado: (2017)

Pleural effusion in 11:14 translocation q1 multiple myeloma in the setting of proteasome inhibitor presents therapeutic complexity
por: Ghannam, Malik, et al.
Publicado: (2018)

Sam68/KHDRBS1-dependent NF-κB activation confers radioprotection to the colon epithelium in γ-irradiated mice
por: Fu, Kai, et al.
Publicado: (2016)

Targeting the fatty acid binding proteins disrupts multiple myeloma cell cycle progression and MYC signaling
por: Farrell, Mariah, et al.
Publicado: (2023)

Blockade of the LRP16-PKR-NF-κB signaling axis sensitizes colorectal carcinoma cells to DNA-damaging cytotoxic therapy
por: Li, Xiaolei, et al.
Publicado: (2017)

Feedback loop in miR‐449b‐3p/ADAM17/NF‐κB promotes metastasis in nasopharyngeal carcinoma
por: Fei, Qian, et al.
Publicado: (2019)

TNF‐α/NF‐κB signaling epigenetically represses PSD4 transcription to promote alcohol‐related hepatocellular carcinoma progression
por: Shi, Jia’ning, et al.
Publicado: (2021)

The impact of bone marrow fibrosis and JAK2 expression on clinical outcomes in patients with newly diagnosed multiple myeloma treated with immunomodulatory agents and/or proteasome inhibitors
por: Paul, Barry, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_v2h7rcauudhj8ug3q2qh87ikr3